Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
39 employees · est. 2006 · Spain
Laminar Pharma is the older company (2012 vs 2006); Formycon AG is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Formycon AG | Laminar Pharma |
|---|---|---|
| Founded | ||
| Founded | 2012 | 2006 older |
| Headquarters | ||
| Headquarters | Planegg, Germany | Spain |
| Employees | ||
| Employees | 171 larger | 39 |
| Industry | ||
| Industry | Biopharma | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $83.13M | $18.20M |
| Funding Rounds | ||
| Funding Rounds | 2 | 5 |
| Services | ||
| Services | Not tracked yet | Design and development of drugs based on melitherapy, Conducting clinical trials, Providing expanded access policies for drug therapies, Collaboration with scientific and medical communities |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with unmet medical needs, Healthcare providers, Pharmaceutical investors, Scientific and clinical research professionals |
| Taxonomy | ||
| Taxonomy | Biosimilars, Biopharmaceuticals, Ophthalmology, Immunology, Chronic Diseases, Drug Development, Clinical Trials, Regulatory Approval, Biotech Drugs, COVID-19 Drug, GMP Quality Control, Formulation Development, Analytical Services, CMC Regulatory Affairs, Project Management | Biopharmaceutical, Membrane-Lipid Therapy, Drug Discovery, Rational Drug Design, Clinical Development, Cancer Treatment, CNS Disorders, Inflammatory Diseases, Metabolic Diseases, Peripheral Proteins, Signal Transduction Modulation, Glioblastoma Treatment, Neurodegenerative Diseases, Spin-off, Therapeutic Strategy |
| Website | ||
| Website | formycon.com | laminarpharma.com |
About Formycon AG
Formycon AG is a biopharmaceutical company based in Germany and was founded in 1999. The company's mission, coined as The Biosimilar Experts, is to develop high-quality biopharmaceutical medicines, especially biosimilars, with a focus on treatments in ophthalmology, immunology, and other key chronic...
About Laminar Pharma
Laminar Pharma, established in 2006, is a pioneering entity within the Biotechnology, Life Sciences, and Pharmaceutical sectors. Based out of Spain, this biopharmaceutical company is making waves with its focus on the groundbreaking "Membrane-Lipid Therapy" (MLT). This innovative approach targets me...
We will tell you when either one moves
BounceWatch watches Formycon AG and Laminar Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Formycon AG and Laminar Pharma — by email.
Frequently Asked Questions
Compare Formycon AG with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Formycon AG on 12 Sep 2024, and Laminar Pharma on 8 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.